Whistleblower papers from inside cigarette giant Philip Morris International reveal the true intentions and strategies behind the company's IQOS non-combustible nicotine product.

The papers show that Philip Morris secretly funded research on harm reduction and cessation, created a comprehensive marketing plan to build support for the product, and targeted dentists and the Olympics for promotion.

The science of IQOS is still uncertain, but evidence suggests that it does not reduce the risk of tobacco-related disease and death, and it may increase exposure to harmful chemicals.

In this episode, we’re joined by Sophie Braznell, Research Coordinator at the Tobacco Control Research Group at the University of Bath and Jorge Alday, Director at STOP, a global tobacco industry watchdog.

They discuss why public health professionals, policymakers, and consumers should be skeptical of the company's claims and take action to counter their marketing push.